Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

SRPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.70%

Insider Buying (Last 12 Months): $4,955,684.40

Insider Selling (Last 12 Months): $11,647,905.42

Sarepta Therapeutics Insider Trading History Chart

Sarepta Therapeutics Share Price & Price History

^$110.63

▼ -1.85 (-1.64%)

As of 11/14/2024 12:03 PM ET

Days: 30 | 90 | 365

The #1 Crypto for AI

From Weiss Ratings | Ad

We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”

Learn more about it by watching THIS NOW.

Sarepta Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Ian Michael Estepan	CFO	Sell	5,985	$137.36	$822,099.60	33,946
8/16/2024	Michael Andrew Chambers	Director	Buy	37,038	$133.80	$4,955,684.40	284,034
6/25/2024	Ryan Edward Brown	EVP	Sell	38,957	$161.61	$6,295,840.77	17,129
6/24/2024	Bilal Arif	Insider	Sell	7,859	$163.08	$1,281,645.72	21,261
5/2/2024	Dallan Murray	Insider	Sell	3,635	$140.00	$508,900.00	18,125
3/11/2024	Kathryn Jean Boor	Director	Sell	761	$122.93	$93,549.73	7,516
3/8/2024	Hans Rudolf Wigzell	Director	Sell	15,000	$123.25	$1,848,750.00	22,840
3/5/2024	Stephen Mayo	Director	Sell	3,135	$122.96	$385,479.60	6,621
3/1/2024	Bilal Arif	Insider	Sell	2,000	$128.84	$257,680.00	26,836
3/1/2024	Ian Michael Estepan	CFO	Sell	1,200	$128.30	$153,960.00	39,114
11/3/2023	Douglas S. Ingram	CEO	Buy	25,225	$79.36	$2,001,856.00	390,307
11/3/2023	Richard Barry	Director	Buy	50,000	$78.81	$3,940,500.00	140,000
8/14/2023	Michael Andrew Chambers	Director	Buy	9,979	$109.47	$1,092,401.13	246,996
8/10/2023	Michael Andrew Chambers	Director	Buy	34,867	$106.15	$3,701,132.05	213,331
8/4/2023	Hans Rudolf Wigzell	Director	Sell	15,000	$106.72	$1,600,800.00	20,994
11/17/2022	Stephen Mayo	Director	Sell	858	$109.92	$94,311.36	6,387
9/14/2022	Michael Andrew Chambers	Director	Buy	57,100	$104.43	$5,962,953.00	108,178
8/19/2022	Michael Andrew Chambers	Director	Buy	46,170	$108.28	$4,999,287.60	51,078
11/24/2021	Louise Rodino-Klapac	Insider	Buy	3,780	$79.33	$299,867.40
11/17/2021	Douglas S. Ingram	CEO	Buy	25,026	$79.94	$2,000,578.44

The #1 Crypto for AI

From Weiss Ratings | Ad

Learn more about it by watching THIS NOW.

SEC Filings (Institutional Ownership Changes) for Sarepta Therapeutics (NASDAQ:SRPT)

86.68% of Sarepta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sarepta Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Alkeon Capital Management LLC	633,845	$79.16M	0.1%	+13.4%	0.664%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	268,203	$33.50M	0.0%	-11.0%	0.281%
11/14/2024	Ally Bridge Group NY LLC	72,000	$8.99M	4.8%	-2.0%	0.075%
11/14/2024	MetLife Investment Management LLC	53,327	$6.66M	0.0%	-1.1%	0.056%
11/14/2024	Blueshift Asset Management LLC	2,096	$0.26M	0.1%	N/A	0.002%
11/13/2024	Finepoint Capital LP	133,535	$16.68M	1.2%	+0.5%	0.140%
11/13/2024	Quantbot Technologies LP	1,900	$0.24M	0.0%	N/A	0.002%
11/13/2024	The Manufacturers Life Insurance Company	74,778	$9.34M	0.0%	-16.5%	0.078%
11/13/2024	Qsemble Capital Management LP	2,489	$0.31M	0.1%	N/A	0.003%
11/13/2024	Fisher Asset Management LLC	18,155	$2.27M	0.0%	+1.3%	0.019%
11/13/2024	Daiwa Securities Group Inc.	3,929	$0.49M	0.0%	+13.8%	0.004%
11/12/2024	Centaurus Financial Inc.	1,251	$0.16M	0.0%	-10.7%	0.001%
11/12/2024	Larson Financial Group LLC	8,749	$1.09M	0.1%	+1,649.8%	0.009%
11/12/2024	Algert Global LLC	69,206	$8.64M	0.2%	+10.6%	0.072%
11/12/2024	Eagle Asset Management Inc.	371,435	$45.17M	0.2%	-8.5%	0.389%
11/12/2024	Charles Schwab Investment Management Inc.	611,749	$76.40M	0.0%	+1.2%	0.640%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	78,244	$9.77M	0.0%	+30.1%	0.082%
11/8/2024	Commerce Bank	2,016	$0.25M	0.0%	+15.7%	0.002%
11/8/2024	Fifth Third Wealth Advisors LLC	3,643	$0.46M	0.0%	-5.1%	0.004%
11/7/2024	Braun Stacey Associates Inc.	103,012	$12.87M	0.5%	+4.9%	0.108%
11/7/2024	Thrivent Financial for Lutherans	624,888	$78.04M	0.1%	-3.1%	0.655%
11/7/2024	AM Squared Ltd	1,400	$0.18M	0.4%	+600.0%	0.001%
11/6/2024	Mutual of America Capital Management LLC	51,542	$6.44M	0.1%	-4.8%	0.054%
11/6/2024	Mizuho Markets Americas LLC	399,065	$49.84M	1.0%	+22.3%	0.418%
11/6/2024	Simplify Asset Management Inc.	193,010	$24.11M	1.1%	+84.6%	0.202%
11/6/2024	CIBC Asset Management Inc	2,712	$0.34M	0.0%	+3.3%	0.003%
11/6/2024	Huntington National Bank	291	$36K	0.0%	+150.9%	0.000%
11/6/2024	Oppenheimer Asset Management Inc.	4,457	$0.56M	0.0%	+3.4%	0.005%
11/5/2024	Victory Capital Management Inc.	66,279	$8.28M	0.0%	-20.2%	0.069%
11/5/2024	Aigen Investment Management LP	1,823	$0.23M	0.0%	-81.4%	0.002%
11/5/2024	Prime Capital Investment Advisors LLC	8,654	$1.08M	0.0%	+3.0%	0.009%
11/5/2024	Platform Technology Partners	2,462	$0.31M	0.1%	+15.2%	0.003%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	1,700	$0.21M	0.0%	+21.4%	0.002%
11/5/2024	WCM Investment Management LLC	10,917	$1.36M	0.0%	+32.5%	0.011%
11/4/2024	State of New Jersey Common Pension Fund D	32,698	$4.08M	0.0%	-0.7%	0.034%
11/4/2024	Crossmark Global Holdings Inc.	7,161	$0.89M	0.0%	+16.1%	0.008%
11/4/2024	Sigma Planning Corp	10,849	$1.36M	0.0%	-3.2%	0.011%
11/1/2024	Assetmark Inc.	39,025	$4.87M	0.0%	+230.6%	0.041%
11/1/2024	Fiera Capital Corp	359,996	$44.96M	0.1%	-5.9%	0.377%
10/31/2024	Principal Financial Group Inc.	267,037	$33.35M	0.0%	-26.4%	0.283%
10/31/2024	Ironsides Asset Advisors LLC	2,605	$0.33M	0.1%	N/A	0.003%
10/31/2024	Advisor Resource Council	1,763	$0.22M	0.1%	N/A	0.002%
10/30/2024	Amalgamated Bank	46,473	$5.80M	0.0%	-4.6%	0.049%
10/30/2024	AlphaCentric Advisors LLC	18,000	$2.25M	1.7%	+140.0%	0.019%
10/30/2024	QRG Capital Management Inc.	1,969	$0.25M	0.0%	N/A	0.002%
10/29/2024	Emerald Advisers LLC	8,338	$1.04M	0.0%	+94.9%	0.009%
10/29/2024	Van ECK Associates Corp	68,176	$8.85M	0.0%	-18.0%	0.072%
10/29/2024	Emerald Mutual Fund Advisers Trust	1,018	$0.13M	0.0%	N/A	0.001%
10/29/2024	Silvant Capital Management LLC	28,009	$3.50M	0.2%	+11.8%	0.030%
10/28/2024	Gladstone Institutional Advisory LLC	83,300	$10.40M	0.5%	+47.7%	0.088%
10/28/2024	US Bancorp DE	6,549	$0.82M	0.0%	+4.3%	0.007%
10/25/2024	Pinnacle Associates Ltd.	91,951	$11.48M	0.2%	+83.5%	0.097%
10/25/2024	First Trust Direct Indexing L.P.	1,635	$0.20M	0.0%	+26.4%	0.002%
10/25/2024	New York State Teachers Retirement System	78,175	$9.76M	0.0%	+2.5%	0.083%
10/25/2024	Highview Capital Management LLC DE	1,972	$0.25M	0.1%	N/A	0.002%
10/25/2024	China Universal Asset Management Co. Ltd.	18,342	$2.29M	0.3%	+65.2%	0.019%
10/25/2024	abrdn plc	431,098	$53.94M	0.1%	+30.7%	0.456%
10/24/2024	Nisa Investment Advisors LLC	1,070	$0.13M	0.0%	+16.9%	0.001%
10/24/2024	Riggs Asset Managment Co. Inc.	2,300	$0.29M	0.1%	+666.7%	0.002%
10/24/2024	State of Alaska Department of Revenue	11,035	$1.38M	0.0%	+7.3%	0.012%
10/24/2024	Valley National Advisers Inc.	225	$28K	0.0%	-35.9%	0.000%
10/24/2024	Wealth Enhancement Advisory Services LLC	4,481	$0.56M	0.0%	-10.0%	0.005%
10/24/2024	PFG Investments LLC	26,674	$3.33M	0.2%	+8.7%	0.028%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	6,002	$0.75M	0.0%	+112.7%	0.006%
10/23/2024	Louisiana State Employees Retirement System	26,400	$3.30M	0.1%	-1.1%	0.028%
10/23/2024	Values First Advisors Inc.	471	$59K	0.0%	N/A	0.000%
10/23/2024	Assenagon Asset Management S.A.	350,052	$43.72M	0.1%	-2.7%	0.370%
10/22/2024	International Assets Investment Management LLC	75,933	$9.48M	0.0%	+59,222.7%	0.080%
10/22/2024	Bank Pictet & Cie Europe AG	2,827	$0.35M	0.0%	+27.7%	0.003%
10/22/2024	Signaturefd LLC	8,107	$1.01M	0.0%	-24.6%	0.009%
10/19/2024	Allspring Global Investments Holdings LLC	508	$63K	0.0%	-97.7%	0.001%
10/19/2024	DMC Group LLC	3,261	$0.41M	0.3%	-4.0%	0.003%
10/18/2024	Blue Trust Inc.	568	$71K	0.0%	+896.5%	0.001%
10/16/2024	nVerses Capital LLC	500	$62K	0.0%	-77.3%	0.001%
10/16/2024	Vontobel Holding Ltd.	1,803	$0.23M	0.0%	-64.5%	0.002%
10/11/2024	Creative Planning	7,677	$0.96M	0.0%	-3.3%	0.008%
10/11/2024	Sapient Capital LLC	8,155	$1.02M	0.0%	-18.5%	0.009%
10/11/2024	VitalStone Financial LLC	2,622	$0.33M	0.2%	N/A	0.003%
10/10/2024	Perfromance Wealth Partners LLC	2,926	$0.37M	0.0%	-26.9%	0.003%
10/9/2024	Tobam	48,890	$6.11M	1.1%	-0.6%	0.052%
10/9/2024	UMB Bank n.a.	383	$48K	0.0%	+105.9%	0.000%
10/8/2024	Connective Portfolio Management LLC	13,000	$1.62M	1.8%	N/A	0.014%
10/5/2024	Handelsbanken Fonder AB	23,815	$2.97M	0.0%	+12.3%	0.025%
9/23/2024	Centaurus Financial Inc.	1,401	$0.22M	0.0%	N/A	0.001%
8/27/2024	Clearbridge Investments LLC	237,354	$37.50M	0.0%	+57.0%	0.251%
8/26/2024	Teachers Retirement System of The State of Kentucky	30,200	$4.77M	0.0%	N/A	0.032%
8/22/2024	Cetera Investment Advisers	13,013	$2.06M	0.0%	+8.5%	0.014%
8/21/2024	Advisory Alpha LLC	1,320	$0.21M	0.0%	-50.9%	0.001%
8/21/2024	Truist Financial Corp	4,003	$0.63M	0.0%	+86.5%	0.004%
8/19/2024	Point72 Asset Management L.P.	48,913	$7.73M	0.0%	-99.7%	0.052%
8/19/2024	EP Wealth Advisors LLC	4,899	$0.77M	0.0%	+2.1%	0.005%
8/16/2024	Northwestern Mutual Wealth Management Co.	250	$40K	0.0%	-87.8%	0.000%
8/16/2024	NewEdge Advisors LLC	5,591	$0.88M	0.0%	-19.6%	0.006%
8/16/2024	Creative Planning	7,937	$1.25M	0.0%	+11.7%	0.008%
8/16/2024	Algert Global LLC	62,552	$9.88M	0.3%	+1.3%	0.066%
8/15/2024	Lighthouse Investment Partners LLC	50,342	$7.95M	0.3%	N/A	0.053%
8/15/2024	Mackenzie Financial Corp	61,261	$9.68M	0.0%	+68.2%	0.065%
8/15/2024	The Manufacturers Life Insurance Company	89,525	$14.15M	0.0%	+121.7%	0.095%
8/15/2024	Point72 Hong Kong Ltd	6,756	$1.07M	0.1%	N/A	0.007%
8/14/2024	Fred Alger Management LLC	318,252	$50.28M	0.2%	+23.6%	0.337%

Data available starting January 2016

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $110.63

$109.63

$112.58

50 Day Range

MA: $124.70

$112.48

$133.77

52 Week Range

Now: $110.63

$78.67

$173.25

Volume

204,192 shs

Average Volume

1,227,662 shs

Market Capitalization

$10.57 billion

P/E Ratio

88.50

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Sarepta Therapeutics?: Sarepta Therapeutics' top insider investors include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Dallan Murray (Insider)
Ryan Edward Brown (EVP)
Kathryn Jean Boor (Director)
Stephen Mayo (Director)
Learn More about top insider investors at Sarepta Therapeutics.
Who are the major institutional investors of Sarepta Therapeutics?: Sarepta Therapeutics' top institutional shareholders include:
Alkeon Capital Management LLC — 0.66%
Thrivent Financial for Lutherans — 0.66%
Charles Schwab Investment Management Inc. — 0.64%
abrdn plc — 0.46%
Mizuho Markets Americas LLC — 0.42%
Eagle Asset Management Inc. — 0.39%
Learn More about top institutional investors of Sarepta Therapeutics stock.
Which institutional investors are selling Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was sold by these institutional investors:
Principal Financial Group Inc.
LMR Partners LLP
Walleye Trading LLC
Eagle Asset Management Inc.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Fiera Capital Corp
Allspring Global Investments Holdings LLC
Thrivent Financial for Lutherans
During the previous year, company insiders that have sold Sarepta Therapeutics company stock include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Dallan Murray (Insider)
Learn More investors selling Sarepta Therapeutics stock.
Which institutional investors are buying Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was bought by institutional investors including:
Summit Partners Public Asset Management LLC
abrdn plc
Simplify Asset Management Inc.
International Assets Investment Management LLC
Alkeon Capital Management LLC
Mizuho Markets Americas LLC
Pinnacle Associates Ltd.
Assetmark Inc.
Within the last year, these company insiders have bought Sarepta Therapeutics stock:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Learn More investors buying Sarepta Therapeutics stock.